Short versus long duration of DAPT after des implantation: A meta-analysis

Journal of the American College of Cardiology

Volumn 64, Issue 9, 2014, Pages 953-954

  Stefanini, Giulio G ^a   Siontis, George C M ^a   Cao, Davide ^a   Heg, Dik ^b   Jüni, Peter ^b   Windecker, Stephan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYPHER; EVEROLIMUS; RAPAMYCIN; UNCLASSIFIED DRUG; ZOTAROLIMUS;

BLEEDING; CORONARY ARTERY DISEASE; DEVICE SAFETY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; HEART DEATH; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; LETTER; META ANALYSIS; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; STENT THROMBOSIS; SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION; TREATMENT WITHDRAWAL;

CARDIOLOGY; DRUG ADMINISTRATION SCHEDULE; DRUG-ELUTING STENTS; HEMORRHAGE; HUMANS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; TREATMENT OUTCOME;

EID: 84907311735     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.06.1158     Document Type: Letter

References (5)

1. G.N. Levine, E.R. Bates, and J.C. Blankenship et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
2. H.C. Gwon, J.Y. Hahn, and K.W. Park et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study Circulation 125 2012 505 513
3. M. Valgimigli, G. Campo, and M. Monti et al. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
4. B.K. Kim, M.K. Hong, and D.H. Shin et al. A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) J Am Coll Cardiol 60 2012 1340 1348
5. F. Feres, R.A. Costa, and A. Abizaid et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial JAMA 310 2013 2510 2522